Skip to main content
. 2021 Mar 26;71(705):185–188. doi: 10.3399/bjgp21X715577

Box 3.

Drugs associated with gynaecomastia

Anti-androgen 5-α reductase inhibitors (finasteride)
Antihypertensive Calcium channel blockers, spironolactone, angiotensin-converting enzyme (ACE) inhibitors
Antiretroviral Protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Antifungal/-microbial Ketoconazole, metronidazole, isoniazid
Antipsychotic Haloperidol, olanzapine, risperidone, ziprasidone, paliperidone, fluoxetine, gabapentin, pregabalin, venlafaxine, aripiprazole, diazepam, amisulpride, quetiapine
Antiparasite Phenothrin
Analgesics Opioids
Cardiovascular Digoxin, amiodarone, statins, clonidine, clopidogrel, sildenafil
Chemotherapy drug Methotrexate, alkylating agents, cisplatin, vincristine, bleomycin, dasatinib, imatinib
Exogenous hormones Oestrogens, steroids, androgens
Gastrointestinal drug Proton pump inhibitors, H2 histamine blockers, domperidone, misoprostol
Illicit and recreational Amphetamines, cannabis, heroin, methadone, alcohol
Herbal supplements Lavender, soy protein, tea tree oil, tribulus, common nettle
Other Theophylline, penicillamine, ivacaftor, gonadotrophin-releasing agents